Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xiangyu Medical CoSHSE:688626 -0.90%91 Days Payable is 167.81 as of Jun. 2026, which is 193% above its 10-year median of 57.19. GuruFocus rates SHSE:688626 with a GF Score™ of 91/100 and a GF Value™ of ¥46.28 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Xiangyu Medical Co ranks better than 83.52% on this metric.
The historical rank and industry rank for Xiangyu Medical Co's Days Payable or its related term are showing as below:
SHSE:688626'
s Days Payable Range Over the Past 10 Years
Min: 31.99 Med: 57.19 Max: 185.34
Current: 185.34
During the past 9 years, Xiangyu Medical Co's highest Days Payable was 185.34. The lowest was 31.99. And the median was 57.19.
SHSE:688626's Days Payable is ranked better than 83.52% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.41
vs SHSE:688626: 185.34
Xiangyu Medical Co's Days Payable
declined
from Jun. 2025 (244.79) to Jun. 2026 (167.81).
It may suggest that Xiangyu Medical Coaccelerated paying its suppliers.
The historical data trend for Xiangyu Medical Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688626 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Xiangyu Medical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xiangyu Medical Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Xiangyu Medical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Xiangyu Medical Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Xiangyu Medical Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xiangyu Medical Co (SHSE:688626) has a Days Payable of 167.81 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Xiangyu Medical Co and its competitors. This is 193% above median its historical median of 57.19. Over the past decade, Xiangyu Medical Co's Days Payable has ranged from 31.99 to 185.34. According to the industry distribution chart, Xiangyu Medical Co ranks #131 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 16.5%.
Is Xiangyu Medical Co's Days Payable too high?
Xiangyu Medical Co's current Days Payable of 167.81 is 193% above median its 10-year median of 57.19. Over the past 10 years, this metric has ranged from a low of 31.99 to a high of 185.34. The Medical Devices & Instruments industry median Days Payable is 68.41. Xiangyu Medical Co's value of 167.81 is 145.3% above this industry median. Based on the distribution chart, Xiangyu Medical Co ranks #131 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Xiangyu Medical Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Xiangyu Medical Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Xiangyu Medical Co ranks #131 out of 795 companies for Days Payable. This places Xiangyu Medical Co in the top 17% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.41. Xiangyu Medical Co's value of 167.81 is 145.3% above this benchmark. Historically, Xiangyu Medical Co's own Days Payable has ranged from 31.99 to 185.34 over the past decade. While the company's 10-year median is 57.19 vs. the industry median of 68.41, Xiangyu Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.41, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xiangyu Medical Co's current Days Payable of 167.81 is 145.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Xiangyu Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xiangyu Medical Co's current Days Payable is 167.81, which is 193% above median its own 10-year median of 57.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xiangyu Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Xiangyu Medical Co (SHSE:688626) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥46.28, compared to a current price of ¥39.72 — trading 14.2% below its estimated fair value. The current Days Payable is 167.81, which is 193% above median its 10-year median of 57.19 and 145.3% above the Medical Devices & Instruments industry median of 68.41. Xiangyu Medical Co's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Xiangyu Medical Co (SHSE:688626), the current Days Payable is 167.81 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xiangyu Medical Co (SHSE:688626) Overvalued in 2026?
Based on GuruFocus' analysis, Xiangyu Medical Co stock appears to be undervalued.
The current stock price of ¥39.72 is trading 14.2% below its estimated GF Value™ of ¥46.28.
GuruFocus considers Xiangyu Medical Co to be Modestly Undervalued.
Key valuation signals for SHSE:688626:
Days Payable: 167.81 (193% above median its 10-year median of 57.19)
GF Value™: ¥46.28 vs. price of ¥39.72 (14.2% below fair value)
Industry Position: 145.3% above the Medical Devices & Instruments median (#131 of 795)
No single metric tells the full story. See the SHSE:688626 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xiangyu Medical Co Ltd is engaged in independent research and development, production and sales of intelligent rehabilitation equipment in the fields of pain rehabilitation, neurorehabilitation, orthopedics rehabilitation, postpartum rehabilitation, and medical care integration. The company's products are divided into three categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy.
91GF Score
Get the complete analysis for SHSE:688626
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688626 has been successfully added to your 
